These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2950328)

  • 1. GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies.
    Pileblad E; Engberg G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):383-7. PubMed ID: 2950328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    Engberg G; Elebring T; Nissbrandt H
    J Pharmacol Exp Ther; 1991 Nov; 259(2):841-7. PubMed ID: 1658311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action.
    Andersen PH
    Eur J Pharmacol; 1989 Aug; 166(3):493-504. PubMed ID: 2530094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.
    Heikkila RE; Manzino L
    Eur J Pharmacol; 1984 Aug; 103(3-4):241-8. PubMed ID: 6237922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the ambulation-increasing effect of GBR-12909, a selective dopamine uptake inhibitor, in mice.
    Hirate K; Kuribara H
    Jpn J Pharmacol; 1991 Apr; 55(4):501-11. PubMed ID: 1832199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat.
    Kelley AE; Lang CG
    Eur J Pharmacol; 1989 Aug; 167(3):385-95. PubMed ID: 2530095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
    Engberg G; Elverfors A; Jonason J; Nissbrandt H
    Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sensitization between cocaine and GBR 12909, a dopamine uptake inhibitor.
    Baldo BA; Kelley AE
    Brain Res Bull; 1991 Jul; 27(1):105-8. PubMed ID: 1834316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBR 12909 fails to antagonize cocaine-induced elevation of dopamine in striatal slices.
    Gifford AN; Bergmann JS; Johnson KM
    Drug Alcohol Depend; 1993 Mar; 32(1):65-71. PubMed ID: 8486086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.
    Gordon I; Weizman R; Rehavi M
    Life Sci; 1994; 55(3):189-99. PubMed ID: 8007761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective dopamine uptake inhibitor GBR 12909: its effects on the microstructure of feeding in rats.
    van der Hoek GA; Cooper SJ
    Pharmacol Biochem Behav; 1994 May; 48(1):135-40. PubMed ID: 8029284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons.
    Gudelsky GA; Nwajei EE; Defife K; Nash JF
    Psychopharmacol Bull; 1992; 28(3):275-9. PubMed ID: 1480731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine uptake inhibition potentiates the effects of L-DOPA on rat substantia nigra zona compacta neurons.
    Mercuri NB; Calabresi P; Bernardi G
    Neurosci Lett; 1991 May; 126(1):79-82. PubMed ID: 1830942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the dopamine neuronal reuptake inhibitor GBR 12909 on the dopaminergic neurotransmission parameters in the rat striatum in vivo].
    Budygin EA; Kilpatrick M; Gaĭnetdinov RR; Raevskiĭ KS; Wightman RM
    Eksp Klin Farmakol; 1999; 62(5):3-6. PubMed ID: 10572741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine.
    Jackson DM; Martin LP; Larsson LG; Cox RF; Waszczak BL; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):290-9. PubMed ID: 2126347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.